Nothing Special   »   [go: up one dir, main page]

DK149850C - METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES

Info

Publication number
DK149850C
DK149850C DK536677A DK536677A DK149850C DK 149850 C DK149850 C DK 149850C DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A DK 149850 C DK149850 C DK 149850C
Authority
DK
Denmark
Prior art keywords
disubst
thiazolidinones
thiones
oxazolidinones
analogue
Prior art date
Application number
DK536677A
Other languages
Danish (da)
Other versions
DK536677A (en
DK149850B (en
Inventor
Andreas Huth
Ralph Schmiechen
Wolfgang Kehr
Gert Paschelke
Helmut Wachtel
Herbert Hans Schneider
Dieter Palenschat
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762655369 external-priority patent/DE2655369A1/en
Priority claimed from DE19772745320 external-priority patent/DE2745320A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK536677A publication Critical patent/DK536677A/en
Publication of DK149850B publication Critical patent/DK149850B/en
Application granted granted Critical
Publication of DK149850C publication Critical patent/DK149850C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK536677A 1976-12-03 1977-12-02 METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES DK149850C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2655369 1976-12-03
DE19762655369 DE2655369A1 (en) 1976-12-03 1976-12-03 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION
DE2745320 1977-10-05
DE19772745320 DE2745320A1 (en) 1977-10-05 1977-10-05 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors

Publications (3)

Publication Number Publication Date
DK536677A DK536677A (en) 1978-06-04
DK149850B DK149850B (en) 1986-10-13
DK149850C true DK149850C (en) 1987-04-27

Family

ID=25771221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536677A DK149850C (en) 1976-12-03 1977-12-02 METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES

Country Status (19)

Country Link
JP (1) JPS5382777A (en)
AT (1) AT357529B (en)
AU (1) AU519994B2 (en)
CA (1) CA1097657A (en)
CH (1) CH635578A5 (en)
CS (1) CS199694B2 (en)
DD (1) DD133667A5 (en)
DK (1) DK149850C (en)
FR (1) FR2372814A1 (en)
GB (1) GB1588639A (en)
GR (1) GR64964B (en)
HU (1) HU175676B (en)
IE (1) IE46435B1 (en)
IL (1) IL53520A (en)
IT (1) IT1089341B (en)
LU (1) LU78616A1 (en)
NL (1) NL7713153A (en)
SE (1) SE441446B (en)
SU (1) SU888821A3 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701215C2 (en) * 1977-01-13 1982-10-14 Bayer Ag, 5090 Leverkusen Process for the preparation of thiazoline-2-thiones
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
DE3438839A1 (en) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
HU215433B (en) * 1986-04-29 2000-05-28 Pfizer Inc. Process for producing new 2-oxo-5-phenyl-pyrimidin derivatives
JPH01135098U (en) * 1988-03-11 1989-09-14
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
JP3806144B2 (en) * 1993-12-22 2006-08-09 セルテック セラピューティックス リミテッド Trisubstituted phenyl derivatives, their preparation and their use as phosphodiesterase (type IV) inhibitors
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
JP2001507349A (en) 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
AT357529B (en) 1980-07-10
DK536677A (en) 1978-06-04
ATA868677A (en) 1979-12-15
SU888821A3 (en) 1981-12-07
GB1588639A (en) 1981-04-29
GR64964B (en) 1980-06-10
LU78616A1 (en) 1978-04-20
DK149850B (en) 1986-10-13
JPS6154792B2 (en) 1986-11-25
IE772446L (en) 1978-06-03
DD133667A5 (en) 1979-01-17
AU3117577A (en) 1979-06-07
NL7713153A (en) 1978-06-06
FR2372814B1 (en) 1980-10-10
CS199694B2 (en) 1980-07-31
IL53520A0 (en) 1978-03-10
HU175676B (en) 1980-09-28
CH635578A5 (en) 1983-04-15
SE441446B (en) 1985-10-07
IE46435B1 (en) 1983-06-15
FR2372814A1 (en) 1978-06-30
IL53520A (en) 1981-07-31
CA1097657A (en) 1981-03-17
SE7713635L (en) 1978-06-04
IT1089341B (en) 1985-06-18
JPS5382777A (en) 1978-07-21
AU519994B2 (en) 1982-01-07

Similar Documents

Publication Publication Date Title
DK149850C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES
DK162601C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 8-OE4-OE4- (2,1-BENZISOTHIAZOL-3-YL) -1-PIPERAZINYLAABUTYLAA-8-AZASPIROOE4.5AADECAN-7,9-DION
DK144010C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2-PIPERAZINYL-6,7-DIMETHOXYQUINAZOLINES OR ACID ADDITION SALTS.
DK462380A (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2,4-DIAMINOQUINAZOLINE COMPOUNDS OR ACID ADDITION SALTS.
DK149111C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF HISTIDIN DERIVATIVES OR ACID ADDITION SALTS.
ES514585A0 (en) PROCEDURE FOR THE OBTAINING OF TRISUSTITUIDED OXAZOL DERIVATIVES.
DK156001C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF MERCAPTOS-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES
NL7904337A (en) AMINOTHIAZOLE DERIVATIVES.
DK301180A (en) METHOD OF PREPARING 5-SUBSTITUTED 2,3-DIARYLTHIOPHENES
DK147468C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 14-CHLOR OR 13,14-DIDEHYDRO-PROSTAGLAND INGREDIENTS
DK149846C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N, N'-BIS-TETRAHYDRO-ISOQUINOLYLD DISULPHONYLIMIDES
DK160092C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2- (2- (1,4-BENZODIOXANYL)) - 2-IMIDAZOLINE OR NON-TOXIC ACID ADDITION SALTS.
DK146281C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 2-BROMO-6-FLUORO-N-2-IMIDAZOLIDINYLIDE-BENZAMINE OR ACID ADDITION SALTS.
DK151255C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N-ALKYNYL-N '- (OMEGA - ((5-SUBSTITUTED-2-FURYL) -ALKYLTHIO) ALKYL) DERIVATIVES OF NAE- (SUBSTITUTED) -GUANIDINE OR OF 1,1 substituted) -ethylene.
DK150511C (en) METHOD FOR PREPARING 3,4-DI-HYDRO-4-OXO-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE-1,1-DIOXIDE COMPOUNDS
DK173379A (en) PROCEDURE FOR THE PREPARATION OF 6ALFA-HALOGEN-3-KETO-DELTA 1,4-PREGNADIAN DERIVATIVES
DK149429C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLIDINE-2,4-DIONE DERIVATIVES OR ACID ADDITION SALTS.
DK158227C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF SUBSTITUTED IMIDAZOOE1,5-AAAPYRIDINES OR 5,6,7,8-TETRAHYDRODE DERIVATIVES OR SALTS THEREOF
DK148281C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 8A-SUBSTITUTED 8,8A-DESOXY-8,8A-DIHYDROOLEANDOMYCINE COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.
DK375380A (en) METHOD FOR PREPARING 5- (CHLORPHENYL) -6H-1,3,4-THIADIAZIN-2-AMINES
DK308180A (en) METHOD FOR PREPARING 2,3-DIHYDRO2,2-DIMETHYL-7-HYDROXYBENZOFURAN
DK151028C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 1,3-TIAZOLO (4,3-A) ISOKINOLINES OR SALTS THEREOF
DK143403C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 8- (1H-TETRAZOL-5-YL) -11H-PYRIDO (2,1-B) QUINAZOLINE-11-ON OR SALTS THEREOF
DK144822C (en) METHOD OF ANALOGY FOR THE PREPARATION OF HIGH-RETIRING 7-BROMO-6-CHLORO-3- (3- (3-HYDROXY-2-PIPERIDYL) -ACETONYL) -4-3H-QUINAZOLINON OR ITS ADDITIONAL SALTS.
DK365879A (en) METHOD FOR PREPARING 4-HYDROXY-2H (1) BENZOTHENO (, 3 -) - 1,2-THIAZIN-3-CARBOXAMIDE-1,1-DIOXIDES

Legal Events

Date Code Title Description
PBP Patent lapsed